Adcare Health Systems (RHE)
(Delayed Data from AMEX)
$1.86 USD
-0.06 (-2.88%)
Updated Aug 30, 2024 03:38 PM ET
After-Market: $1.86 +0.01 (0.27%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Adcare Health Systems Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 17 | 36 | 27 | 18 | 20 |
Cost Of Goods | 10 | 21 | 10 | 1 | 1 |
Gross Profit | 7 | 15 | 17 | 17 | 19 |
Selling & Adminstrative & Depr. & Amort Expenses | 8 | 22 | 14 | 15 | 14 |
Income After Depreciation & Amortization | -1 | -7 | 3 | 2 | 5 |
Non-Operating Income | 0 | 2 | -1 | 0 | 5 |
Interest Expense | 3 | 3 | 3 | 3 | 5 |
Pretax Income | -4 | -7 | -1 | -1 | 5 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -4 | -7 | -1 | -1 | 5 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 1 |
Net Income (GAAP) | -4 | -7 | -1 | -1 | 6 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 2 | -4 | 5 | 5 | 9 |
Depreciation & Amortization (Cash Flow) | 2 | 2 | 3 | 3 | 4 |
Income After Depreciation & Amortization | -1 | -7 | 3 | 2 | 5 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 1.88 | 1.78 | 1.73 | 1.69 | 1.69 |
Diluted EPS Before Non-Recurring Items | -21.05 | -8.93 | -5.84 | -5.69 | -2.44 |
Diluted Net EPS (GAAP) | 21.05 | -8.93 | -5.87 | -5.74 | -2.07 |
Fiscal Year end for Adcare Health Systems Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 4.33 | 4.13 | 4.52 | 4.14 | 4.60 |
Cost Of Goods | 2.18 | 2.10 | 2.34 | 2.47 | 2.31 |
Gross Profit | 2.14 | 2.03 | 2.18 | 1.67 | 2.29 |
SG&A, R&D, and Dept/Amort Expenses | 1.92 | 2.32 | 2.02 | 2.08 | 2.11 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.22 | -0.29 | 0.16 | -0.41 | 0.18 |
Non-Operating Income | -0.25 | 0.01 | 0.29 | 0.14 | -0.19 |
Interest Expense | 0.67 | 0.67 | 0.68 | 0.71 | 0.68 |
Pretax Income | -0.71 | -0.96 | -0.24 | -0.97 | -0.69 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -0.71 | -0.96 | -0.24 | -0.97 | -0.69 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -0.71 | -0.96 | -0.24 | -0.97 | -0.69 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 1.85 | 1.84 | 1.83 | 1.88 | 1.88 |
Diluted EPS Before Non-Recurring Items | -0.38 | -0.52 | -0.13 | -0.52 | 22.68 |
Diluted Net EPS (GAAP) | -0.38 | -0.52 | 1.17 | -0.52 | 22.68 |